CLINICAL_TRIALS
ClinicalTrials.gov record update
Etude Phase I/II d'immunothérapie Par protéine recWT1-A10+AS01B après Greffe allogénique de Cellules Souches
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT01819558
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:35:58.209648+00:00
- Published At
- 2015-03-20T00:00:00+00:00
- Record Updated At
- 2015-03-20
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Acute Myeloid Leukemia", "Chronic Myeloid Leukemia", "Myelodysplastic Syndrome"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2015-03-20"- protocolSection.identificationModule.nctId
"NCT01819558"- protocolSection.identificationModule.officialTitle
"Etude Phase I/II d\u0027immunoth\u00e9rapie Par prot\u00e9ine recWT1-A10+AS01B apr\u00e8s Greffe allog\u00e9nique de Cellules Souches"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE1", "PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.